Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Jit

Showing results (271-280 of 388) with videos related to

Pageof 39
Sort By:
Vaccine|April 12, 2025
Regional cooperation on pandemic preparedness and vaccine equity from an economic, regulatory and legal perspectiveMei Xuan Jessalyn Chan, Olivier J Wouters, Hui Yun Chan, et al.
Vaccine|June 7, 2022
COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recoveryJaspreet Toor, Xiang Li, Mark Jit, et al.
Royal Society Open Science|August 12, 2022
Optimal health and economic impact of non-pharmaceutical intervention measures prior and post vaccination in England: a mathematical modelling studyMichael J Tildesley, Anna Vassall, Steven Riley, et al.
British Journal of Cancer|June 9, 2020
Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)Maria Kyrgiou, Marc Arbyn, Christine Bergeron, et al.
BMC Medicine|April 21, 2024
Impact of COVID-19 pandemic on depression incidence and healthcare service use among patients with depression: an interrupted time-series analysis from a 9-year population-based studyVivien Kin Yi Chan, Yi Chai, Sandra Sau Man Chan, et al.
PLOS Global Public Health|March 24, 2023
What, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in NigeriaFrancis J Ruiz, Sergio Torres-Rueda, Carl A B Pearson, et al.
BMC Medical Research Methodology|November 8, 2018
Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)Macey L Murray, Jade Meadows, Caroline J Doré, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2018
Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and Its Opportunity Costs for Nonadmitted PatientsFrank G Sandmann, Laura Shallcross, Natalie Adams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 25, 2016
Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With MenAllen Lin, Koh J Ong, Peter Hobbelen, et al.
BMJ Global Health|July 12, 2023
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countriesAllison Portnoy, Rebecca A Clark, Chathika K Weerasuriya, et al.
Pageof 39

Showing results (271-280 of 388) with videos related to

Sort By:
Pageof 39
Vaccine|April 12, 2025
Regional cooperation on pandemic preparedness and vaccine equity from an economic, regulatory and legal perspectiveMei Xuan Jessalyn Chan, Olivier J Wouters, Hui Yun Chan, et al.
Vaccine|June 7, 2022
COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recoveryJaspreet Toor, Xiang Li, Mark Jit, et al.
Royal Society Open Science|August 12, 2022
Optimal health and economic impact of non-pharmaceutical intervention measures prior and post vaccination in England: a mathematical modelling studyMichael J Tildesley, Anna Vassall, Steven Riley, et al.
British Journal of Cancer|June 9, 2020
Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)Maria Kyrgiou, Marc Arbyn, Christine Bergeron, et al.
BMC Medicine|April 21, 2024
Impact of COVID-19 pandemic on depression incidence and healthcare service use among patients with depression: an interrupted time-series analysis from a 9-year population-based studyVivien Kin Yi Chan, Yi Chai, Sandra Sau Man Chan, et al.
PLOS Global Public Health|March 24, 2023
What, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in NigeriaFrancis J Ruiz, Sergio Torres-Rueda, Carl A B Pearson, et al.
BMC Medical Research Methodology|November 8, 2018
Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)Macey L Murray, Jade Meadows, Caroline J Doré, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2018
Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and Its Opportunity Costs for Nonadmitted PatientsFrank G Sandmann, Laura Shallcross, Natalie Adams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 25, 2016
Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With MenAllen Lin, Koh J Ong, Peter Hobbelen, et al.
BMJ Global Health|July 12, 2023
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countriesAllison Portnoy, Rebecca A Clark, Chathika K Weerasuriya, et al.
Pageof 39